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Abstract
Whether cytokines can influence the adaptive immune response by antigen-specific γδ T cells 
during infections or vaccinations remains unknown. We previously demonstrated that, during 
BCG/Mycobacterium tuberculosis (Mtb) infections, Th17-related cytokines markedly upregulated 
when phosphoantigen-specific VγVδ2 T cells expanded. In this study, we examined the 
involvement of Th17-related cytokines in the recall-like responses of Vγ2Vδ2 T cells following 
Mtb infection or vaccination against TB. Treatment with IL-17A/IL-17F or IL-22 expanded 
phosphoantigen 4-hydroxy-3-methyl-but-enyl pyrophosphate (HMBPP)-stimulated Vγ2Vδ2 T 
cells from BCG-vaccinated macaques but not from naïve animals, and IL-23 induced greater 
expansion than the other Th17-related cytokines. Consistently, Mtb infection of macaques also 
enhanced the ability of IL-17/IL-22 or IL-23 to expand HMBPP-stimulated Vγ2Vδ2 T cells. When 
evaluating IL-23 signaling as a prototype, we found that HMBPP/IL-23-expanded Vγ2Vδ2 T cells 
from macaques infected with Mtb or vaccinated with BCG or Listeria ΔactA prfA*-ESAT6/
Ag85B produced IL-17, IL-22, IL-2, and IFN-γ. Interestingly, HMBPP/IL-23-induced production 
of IFN-γ in turn facilitated IL-23-induced expansion of HMBPP-activated Vγ2Vδ2 T cells. 
Furthermore, HMBPP/IL-23-induced proliferation of Vγ2Vδ2 T cells appeared to require APC 
contact and involve the conventional and novel protein kinase C signaling pathways. These 
findings suggest that Th17-related cytokines can contribute to recall-like expansion and effector 
function of Ag-specific γδ T cells after infection or vaccination.
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 Introduction
IL-17A/IL-17F, IL-22, and IL-23 cytokines can be classified as Th17/Th22-related 
cytokines, as Th17 and/or Th22 cells [1, 2] are usually polarized or induced by IL-6, TGF-β, 
and IL-1β, and expanded by IL-23 [3, 4]. IL-17/IL-22 can be produced by CD4+/CD8+/
γδ/NKT cells [5–9], whereas IL-23 is dominantly produced by dendritic cells and 
macrophages [10]. IL-17A and IL-17F have been shown to exhibit pleiotropic biological 
activities on neutrophils, fibroblasts, endothelial/epithelia cells [11–13], while IL-22 can 
regulate keratinocytes involved in skin inflammation [14] or exhibit anti-Mycobacterium 
tuberculosis (Mtb) effector function in vitro [15]. To date, none of theTh17-related cytokines 
has been shown to act alone to significantly induce recall-like expansion/effector functions 
of naïve T cells [16, 17].
Human γδ T cells appear to be nonclassical T cells that contribute to both innate and 
adaptive immune responses [18–21]. Dominant Vγ2Vδ2 T cells exist only in human/
nonhuman primates and remain the sole γδ T-cell subset capable of recognizing 
phosphoantigen (E)-4-hydroxy-3-methyl-but-enyl pyrophosphate (HMBPP) from Mtb, M. 
bovis BCG, Listeria monocytogenes, and other pathogens [22, 23]. Although recall-like 
immune responses of Vγ2Vδ2 T cells have been demonstrated during infections with 
HMBPP-producing Mtb, BCG, or L. monocytogenes [24, 25], the immune mechanisms by 
which these memory-like responses develop after infections remain unknown.
Recent studies have elucidated the molecular interaction between the Vγ2Vδ2 TCR and 
HMBPP presented on APC membranes [26–28], making it possible to focus on HMBPP/
TCR-stimulated and cytokine-driven cellular signals required for γδ T-cell responses. Of 
note, we have recently demonstrated that Mtb and BCG infections can induce high-level 
expression of Th17-related cytokine genes but not IL-2 [29, 30], and that the upregu-lation 
of IL-22 and IL-23 coincides with the expansion of Vγ2Vδ2 T cells in lungs and lymphoid 
organs [25]. We therefore hypothesize that Th17-related cytokines may stimulate recall-like 
expansion/effector functions of Vγ2Vδ2 T cells in HMBPP-producing microbial infections. 
To test this hypothesis, we produced and purified these Th17-related cytokines and assessed 
each of them for the ability to function as growth factors conferring adaptive-like immune 
responses after infection of macaques with HMBPP-producing Mtb, BCG, or L. 
monocytogenes.
 Results and discussion
 Th17 cytokines induce a greater HMBPP-stimulated Vγ2Vδ2 T-cell expansion in BCG-
vaccinated monkeys
We previously demonstrated that major expansion of Vγ2Vδ2 T cells coincided with 
upregulation of Th17-related cytokines during mycobacterial infections [25, 29]. We 
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therefore sought to determine whether IL17-A/IL17-F, IL-22, or IL-23 could facilitate 
HMBPP activation and expansion of Vγ2Vδ2 T cells in mycobacterial infection. We 
successfully produced and purified macaque IL-17A, IL-17F, and IL-22 (Fig. 1A, top) by 
employing our pXmh vector/L. lactis PA1001 expression system [31]. Considerably pure 
IL-17A, IL-17F, and IL-22 were obtained after Ni-NTA column purification of the 
concentrated supernatant (Fig. 1A, bottom). Macaque IL-23 heterodimer was nonproducible, 
so we used recombinant human IL-23 that cross-activates macaque Vγ2Vδ2 T cells.
PBMC from BCG-infected monkeys were cultured with each of these cytokines in the 
absence or presence of HMBPP. In the absence of HMBPP, almost no proliferation or 
expansion of Vγ2Vδ2 T cells was induced by IL-17A, IL-17F, IL-22, or IL-23 in cultures 
(Fig. 1B and C). In the presence of HMBPP, however, IL-17A/IL-17F, IL-22, or IL-23 
induced detectable proliferation/expansion of Vγ2Vδ2 T cells in PBMC from BCG-
vaccinated macaques, with IL-23 promoting greater expansion than other Th17-related 
cytokines (Fig. 1B and C). In contrast, controls including supernatant from L. lactis carrying 
empty plasmid did not expand HMBPP-stimulated Vγ2Vδ2 T cells (data not shown). 
Interestingly, while HMBPP and IL-23 coculture of PBMCs from BCG-vaccinated monkeys 
could expand Vγ2Vδ2 T cells up to the level of 50–60% in CD3+ T cells (Fig. 1B and C), 
PBMC from naïve macaques exhibited much lower levels of Vγ2Vδ2 T cell expansion by 
HMBPP and IL-23 or other Th17-type cytokines (Fig. 1D). Of note, IL-17/IL-22 and IL-23 
seemed to act differently from IL-2, as IL-2 induced similar expansions of Vγ2Vδ2 T cells 
from both naïve and BCG-vaccinated animals (Fig. 1D). Thus, while IL-2 acted similarly on 
γδ T cells regardless of infections, Th17 cytokines induced greater expansion of HMBPP-
stimulated Vγ2Vδ2 T cells from BCG-vaccinated monkeys than those from naïve animals.
It is interesting to note that after BCG vaccination or infection, Th17-related cytokines, 
particularly IL-23, can function as a 2nd signal to induce or enhance the ability of Vγ2Vδ2 T 
cells to mount in vitro recall-like expansion in response to the 1st stimulation signal from 
HMBPP engagement of the TCR. This finding is in agreement with our previous in vivo 
observation demonstrating that Vγ2Vδ2 T cells are able to develop adaptive immune 
responses during BCG, Mtb, and listerial infections of macaques [25, 32]. The HMBPP/
IL-23-induced recall-like expansion of Vγ2Vδ2 T cells induced by Th17-related cytokines is 
somehow consistent with the upregulation of IL-22 and IL-23 during BCG and Mtb 
infections of macaques [25, 29]. In fact, up to 1000-fold overexpression of IL-22, IL-23, or 
IFN-γ can be detected in blood, lymphoid, and lung tissues during BCG/Mtb infection ([29], 
and data not shown). Such remarkable expression of IL-22, IL-23, and IFN-y is indeed 
found coincident with the major increases in numbers of circulating and pulmonary Vγ2Vδ2 
T cells after BCG and Mtb infections [25, 29]. In contrast, IL-2 is almost undetectable in the 
blood and lymphoid tissues, along with very low levels of TNF-α, at the time the expansion 
of Vγ2Vδ2 T cells occurs during active BCG and Mtb infections [25, 29]. Thus, IL-23 and 
IL-22 are likely among the major cytokines driving the in vivo expansion or recall-like 
expansion of HMBPP-specific Vγ2Vδ2 T cells during mycobacterial infections.
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 IL-23 or IL-17/IL-22 is able to expand HMBPP-activated Vγ2Vδ2 T cells in Mtb-infected 
macaques
To authenticate HMBPP/Th17 cytokine-driven expansion of Vγ2Vδ2 T cells in BCG-
vaccinated macaques, we examined whether Mtb infection also enhanced the ability of Th17 
cytokines to expand HMBPP-activated Vγ2Vδ2 T cells. In prospective experiments before 
and after infection, we found that Vγ2Vδ2 T cells in PBMC collected after Mtb infection of 
macaques [33] were able to mount in vitro recall-like expansion in response to costimulation 
with HMBPP and IL-17/22 or IL-23 (Fig. 2A and B). In a separate study, naïve macaques 
were first vaccinated with saline, BCG, and attenuated Mtb mutant (ΔlysA ΔsecA2), 
respectively, as we previously described [34], and 3 months later were infected with Mtb. 
The recall-like expansion of Vγ2Vδ2 T cells was also seen after Mtb infection of naïve, 
BCG-, or MtbΔlysA ΔsecA2-vaccinated macaques (Fig. 2C). Here, Mtb infection appears to 
be the primary driving force for in vitro recall like expansion of Vγ2Vδ2 T cells, as the 
magnitude of γδ T-cell expansion is similar after Mtb infection of naïve and vaccinated 
macaques.
 IL-23-driven expansion is reduced by blockade of IL-23 signaling in Mtb-infected 
macaques
We assessed cytokine/receptor (R) involvement in HMBPP/Th17 cytokine-driven recall-like 
expansion of Vγ2Vδ2 T cells. We evaluated IL-23R expression and anti-IL23R blockade as 
prototypes, because IL-23 caused greater expansion of HMBPP-stimulated γδ T cells than 
did other Th17 cytokines; and anti-human IL-23R Ab had been shown to cross-react with 
macaque IL-23R. Here, our focus on IL-23 blockade is also justified by the finding that in 
vivo recall expansion of Vγ2Vδ2 T cells correlates with upregulation of IL-23, but not IL-2 
or TNF-α [25, 29]. Since HMBPP specifically activates Vγ2Vδ2 T cells only, we explored 
whether IL-23R expression was detectable in HMBPP/IL-23-expanded γδ T cells. Although 
cytokine receptors were often difficult to detect/distinguish by flow cytometry [35], we 
found that IL-23R was apparently expressed on HMBPP/IL-23-expanded Vγ2Vδ2 T cells 
(Fig. 3A and B). In parallel, we examined whether IL-23/IL-23R interaction leading to 
expansion of HMBPP-activated Vγ2Vδ2 T cells could be blocked by anti-IL-23R blocking 
Ab, as IL-23 signaling involves Janus kinase 2, STAT2, and positive feedback enhancement 
[36, 37]. We found that anti-IL23R, but not IgG isotype control, could indeed block IL-23-
induced expansion of HMBPP-stimulated Vγ2Vδ2 T cells (Fig. 2A and C), indicating that 
the IL-23/IL-23R signaling mediates expansion of HMBPP-stimulated Vγ2Vδ2 T cells. The 
remarkable IL-23 blockade suggests that IL-23 provides cosignaling and feedback-
enhancing effects [37] on the expansion of Vγ2Vδ2 T cells.
 HMBPP/IL-23-expanded Vγ2Vδ2 T cells produce IL-17, IL-22, IL-2, and IFN-γ
We then sought to determine whether HMBPP/IL-23-expanded Vγ2Vδ2 T cells from 
infected macaques exhibited effector function for producing IL-17/IL-22 and Th1-type 
cytokines. To this end, PBMC from macaques infected with Mtb, or vaccinated with BCG or 
Listeria ΔactAprfA* mutant [32] were cocultured with HMBPP and IL-23, and assessed for 
the ability to produce IL-17, IL-22, IL-4, IFN-γ, and TGF-β using intracellular cytokine 
staining and ELISA assays. Interestingly, intracellular cytokine staining and flow cytometry 
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analysis revealed that HMBPP/IL-23-expanded Vγ2Vδ2 T cells from Mtb-infected 
macaques produced IFN-y, IL-22, and IL-17 (Fig. 3A and B, Supporting Information Fig. 1). 
Consistently, ELISA of culture supernatants showed that copious amounts of IFN-γ, IL-2, 
and IL-17 were secreted by HMBPP/IL-2-expanded Vγ2Vδ2 T cells from macaques 
immunized with attenuated recombinant (r) Listeria ΔactA prfA*-ESAT6/Ag85B vaccine 
(Fig. 3C), with very little production of IL-4 or TGF-β (data not shown). The IFN-γ 
production was also seen in HMBPP/IL-23 costimulation of Vγ2Vδ2 T cells from BCG-
vaccinated macaques (Fig. 3D). Thus, HMBPP/IL-23 costimulation of PBMC from 
mycobacterium or listeria-infected macaques appears to differentiate Vγ2Vδ2 T cells into T 
effector cells producing IL-17, IL-22, IL-2, and IFN-γ. The results suggest that 
mycobacterial or listerial infection may prime or sensitize Vγ2Vδ2 T cells for HMBPP/
IL-23-mediated differentiation. It has recently been shown that a two-week coculture 
protocol using HMBPP plus IL-1β, IL-6, IL-23, and TGF-β cocktails followed by IL-2 
and/or PMA/ionomycin stimulation could polarize naïve human Vγ2Vδ2 T cells into 
effector cells capable of producing IFN-γ, IL-17, and IL-22 [17] or dominantly producing 
IL-17 [16]. Our results suggest that mycobacterial/listerial infections or immunization of 
macaques may indeed allow Vγ2Vδ2 T cells to bypass many other cytokines signals 
required for producing IFN-γ, IL-17, and IL-22. Such simplicity implicates the adaptive-like 
differentiation feature of Vγ2Vδ2 T cells.
HMBPP/IL-23-activated Vγ2Vδ2 T effector cells can produce IFN-γ in addition to IL-17, 
IL-22, and IL-2, and somehow may differ from CD4+ Th17 cells which exhibit IL-23-driven 
domi- nant production of IL-17 and IL-22 [38]. The production of IFN-γ by Vγ2Vδ2 T cells 
may be the intrinsic immune feature of HMBPP activation of Vγ2Vδ2 TCR [39], as large 
amounts of IFN-γ can also be produced after HMBPP-activated Vγ2Vδ2 T cells are 
expanded by IL-2 ([40, 41], Fig. 3) and by variant IL-4 [35]. This intrinsic immune feature 
may help to explain why cHMBPP/IL-2 expansion/differentiation of these Vγ2Vδ2 T 
effector cells producing IFN-γ and other anti-TB cytokines during Mtb infection can 
increase resistance to TB in macaques [42].
 HMBPP/IL-23-induced production of IFN-γ facilitates IL-23-induced expansion of Vγ2Vδ2 
T cells
It is currently unknown whether Ag/IL-23-induced production of selected cytokines can in 
turn facilitate IL-23 expansion of Ag-specific T cells, although IL-23 is one of the essential 
cytokines driving IL-17 production by αβ CD4+ T cells [1, 2] and by Vγ2Vδ2 T cells [16, 
17]. Now, the production of IFN-γ or IL-17 by HMBPP/IL-23-expanded Vγ2Vδ2 T cells 
raised a mechanistic question as to whether HMBPP/IL-23-driven production of IFN-γ or 
IL-17 could exert positive-feedback regulation of Vγ2Vδ2 T-cell proliferation and 
expansion. To address this question, we set up cytokine-neutralizing experiments to examine 
if anti-IFN-γ or anti-IL-17 neutralizing antibody could reduce or inhibit the HMBPP/IL-23-
induced expansion of Vγ2Vδ2 T cells from infected macaques. Interestingly, anti-IFN-γ 
neutralizing antibody, but not anti-IL-17, anti-IL-4, or anti-TGF-β, significantly inhibited the 
HMBPP/IL-23-induced recall-like expansion of Vγ2Vδ2 T cells at a dose-dependent fashion 
(Supporting Information Fig. 2A and B). The IFN-γ involvement appears to consist with the 
in vivo upregulation of IFN-γ and coincident expansion of Vγ2Vδ2 T cells in Mtb/BCG 
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infection [25, 29]. Although there was no upregulation of IL-2 during in vivo expansion of 
Vγ2Vδ2 T cells in mycobacterial infections [25, 29], neutralizing anti-IL-2 Ab moderately 
reduced HMBPP/IL-23-mediated expansion of Vγ2Vδ2 T cells in Mtb-infected subjects 
(data not shown). Therefore, these results demonstrate that while HMBPP/IL-23-activated 
Vγ2Vδ2 T cells produce IFN-γ, IL-4, IL-2, TGF-β, and IL-17, HMBPP/IL-23-induced IFN-
y production facilitates IL-23-mediated recall-like expansion of Vγ2Vδ2 T cells from 
infected macaques, implicating mutual regulation of γδ T cells by IL-23 and IFN-γ.
 HMBPP/IL-23-induced proliferation of Vγ2Vδ2 T cells requires APC contact
Since infection or vaccination could enhance the ability of Th17-related cytokines to expand 
HMBPP-stimulated Vγ2Vδ2 T cells, we asked whether such in vitro recall-like responses of 
HMBPP-stimulated γδ T cells might be attributed partially to an augmented cross-talk [41] 
between quickly activated γδ T cells and APC from infection-primed macaques. We again 
focused on IL-23, as IL-23 expanded Vγ2Vδ2 T cells more efficiently than did IL-17 and 
IL-22. To this end, we cultured purified Vγ2+ T cells alone without monocytes/macrophages 
(tentatively termed APC). Vγ2Vδ2 T cells were purified from PBMC of BCG-vaccinated 
macaques using immunomagnetic beads as previously described [32], labeled with CFSE, 
and assessed for proliferation without APC in the presence of IL-23 plus HMBPP, IL-2 plus 
HMBPP, or HMBPP alone. Interestingly, in the absence of APC, IL-23 plus HMBPP 
induced little proliferation of Vγ2+ T cells, whereas IL-2 plus HMBPP stimulated 
appreciable proliferation of Vγ2+ T cells (Supporting Information Fig. 3A/upper panel). 
This initial result suggested that physical APC contact and/or additional signal from APC 
were required for the ability of IL-23 to expand HMBPP-stimulated Vγ2Vδ2 T cells. To 
address this, we made use of a trans-well coculture system in which Vγ2+ T cells labeled 
with CFSE were placed in the upper chamber and Vγ2-depleted PBMC containing APC 
were seeded in the lower compartment. This non-contact system allowed free transport and 
permeability of media and cytokines/soluble factors, but prevented Vγ2+ T cells from direct 
contact with APC. IL-2 plus HMBPP reproducibly induced APC-independent proliferation 
of activated Vγ2+ T cells (Supporting Information Fig. 3A/lower panel). In contrast, IL-23 
failed to induce proliferation and expansion of HMBPP-activated Vγ2+ T cells in the 
absence of APC in the trans-well coculture system (Supporting Information Fig. 3A/lower 
panel). To confirm this, monocytes were isolated through adherence and cocultured with 
purified Vγ2+ T cells for proliferation assay. When autologous monocytes were added back 
to the culture of Vγ2+ T cells, IL-23 induced proliferation of HMBPP-stimulated Vγ2Vδ2 T 
cells (Supporting Information Fig. 3B). These results suggest that cell-cell contact between 
Vγ2Vδ2 T cells and APC was required for IL-23-induced proliferation of HMBPP-
stimulated Vγ2Vδ2 T cells.
It is currently unknown why APC contact is needed for recall like expansion of Vγ2Vδ2 T 
cells by HMBPP/IL-23. One would speculate that high-level expression of butyrophilin 3A1 
on APC is needed to trigger the HMBPP-driven TCR activation signaling and IL-23 
signaling. However, this speculation is not supported by the fact that T-cell presentation of 
HMBPP can occur [26] and that IL-2/HMBPP costimulation can still induce proliferation of 
Vγ2Vδ2 T cells without APC. It is likely that HMBPP/IL-23-induced recall like expansion 
of Vγ2Vδ2 T cells may involve additional signal(s) and/or cytokine(s) from APC. Further 
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studies employing better model systems are needed to elucidate detailed sequential and 
complex cytokines/signals for HMBPP/IL-23-driven responses in the context of APC 
contacts. Nevertheless, the current APC experiment demonstrates that APC contact is 
needed for HMBPP/IL-23-driven responses.
 HMBPP/IL-23 expansion of Vγ2Vδ2 T cells involves conventional and novel protein 
kinase C pathways
It has recently been shown that activation of Vγ2Vδ2 T cells by IPP plus IL-2 initiates the 
activation of both conventional PKC (α/β) and novel PKC (PKC θ) isoforms [43]. Data 
suggest that PKC θ appears to be ligand-dependent, whereas activation of PKC α/β tends to 
be driven by growth factor IL-2. Since IL-23 differed from IL-2 in preferential expansion of 
Vγ2Vδ2 T cells from infected or vaccinated macaques, we examined whether HMBPP/
IL-23-induced activation involved different PKC isoforms. To address this, we assessed PKC 
α/β inhibitor GO6976 and PKC θ inhibitor rottlerin, respectively, for the ability to inhibit 
HMBPP/IL-23-induced proliferation of Vγ2Vδ2 T cells. The results showed that either 
GO6976 or rottlerin indeed inhibited the HMBPP/IL-23-induced proliferation of Vγ2Vδ2 T 
cells (Supporting Information Fig. 3C), suggesting that both PKC α/β and PKC θ are the 
downstream signaling kinases involved in HMBPP/IL-23-induced proliferation of Vγ2Vδ2 T 
cells. It is noteworthy that IL-23 signaling alone involves Janus kinase 2, STAT2 and positive 
feedback expansion of Th17 cells [36, 37]. It is likely that IL-23 may additionally involve 
the PKC α/β signaling, whereas HMBPP predominantly engages in the PKC θ pathway [43].
Thus, the current study provides evidence supporting the hypothesis that Th17-related 
cytokines, particularly IL-23, are involved in the in vitro recall-like responses of Vγ2Vδ2 T 
cells after infection with HMBPP-producing Mtb and other microbes. These findings 
provide rationale for the manipulation of HMBPP/IL-23-driven Vγ2Vδ2 T-cell responses for 
the enhancement of antimicrobial immunity.
 Materials and methods
 Animals, vaccination, or infection
Four- to eight-year-old cynomolgus macaques with 3–5 kg body weights were used in this 
study. Monkeys were vaccinated with saline or BCG (106 CFU) as previously described 
[25], infected with Mtb (500 CFU) via bronchoscope-guided spread into bron-choalveolar 
interface [33], or immunized with recombinant (r) Listeria ΔactΔprfA* vaccine expressing 
ESAT6/Ag85B (108 CFU) via oral/intratracheal vaccination [32]. All animals were 
maintained and used in accordance with guidelines of the institutional animal care and use 
committee.
 Expression, purification, and characterization of recombinant macaque IL-17A, IL-17F, 
and IL-22
The coding sequence of macaque IL-17A, IL-17F, or IL-22 cDNA was cloned into the 
pXmh vector to express a protein tagged with C-terminal 6-his, and electroporated into 
Lactococcus lactis stain PA1001 for secretion of each of these cytokines as we previously 
described [31]. Vector pXmh is a derivative of L. lactis expression vector pPA3, by which 
Shen et al. Page 7













expressed protein contains a c-myc tag for Western blotting analysis with anti c-myc 
antibody (clone 9E10, Sigma-Aldrich) and a 6-his tag for purification [35]. Details in 
production, purification, and characterization are described in the Supporting Information 
section. Approximately 150 μg of IL-17A and 300 μg of IL-17F or IL-22 were purified from 
1 L culture supernatant based on the measurement with BCA protein assay [35].
 In vitro stimulation and expansion of Vγ2Vδ2 T cells by HMBPP and Th17-related 
cytokines
PBMCs were isolated from EDTA-treated blood from macaques using Ficoll-Paque 
Plusdensity gradient centrifugation and then cultured with RPMI1640 media supplemented 
with 2 mM glu-tamine, 50 U/mL of penicillin and 50 μg/mL of streptomycin, and containing 
10% FBS (Invitrogen). Cells (1 × 106/mL) were cultured in U-bottomed 96-well plates in 
the absence or presence of 50 ng/mL of HMBPP (provided by Dr. Hassan Jomaa from 
Justus-liebig-University Giessen, Giessen, Germany), and then supplemented at day 0, 3, 
and 5 with 20 U/mL hIL-2 (Sigma-Aldrich), 100 ng/mL hIL-23 (R&D Systems, 
Minneapolis, MN), 100 ng/mL of recombinant macaque IL-17A, IL-17F, or IL-22 
(recombinant human IL-22 from R&D was also used, with similar effects on Vγ2Vδ2 T 
cells). At day 7, cells were harvested for surface or intracellular cytokine staining and flow 
cytometry analyses.
 Isolation of Vγ2+ T cells, CFSE labeling, and proliferation assays
This is essentially the same as previously described. [44]. Vγ2+ T cells were purified from 
PBMCs through incubation with purified mouse-anti-human Vγ2 Ab (Clone: 7A5, Pierce), 
followed by goat-anti-mouse IgG microbeads (Miltenyi Biotec, Germany) at 4°C for 20 min 
for each incubation. Cells were subjected to positive magnetic separation, and Vγ2+ T cells 
and unbound cells fractions were collected, respectively. The purity of positively selected 
Vγ2+ T cells was over 95%, as assessed by flow cytometry.
Purified Vγ2+ T cells were labeled with CFSE by using Cell-trace CFSE cell proliferation 
kit (Invitrogen) following the manufacturer’s protocol. Then Vγ2+ T cells and Vγ2-depleted 
PBMCs were cultured in the upper and lower chambers, respectively, in the transwell system 
(Corning, Acton, MA), which could separate Vγ2+ from other cells by a permeable 
membrane (pore size 0.4 (μm). Cells were cultured in chambers for 7 days with media only, 
HMBPP, HMBPP plus IL-2, or HMBPP plus IL-23 and collected for proliferation assay. In 
parallel, PBMCs from same monkeys were labeled with CFSE and cultured in U-bottomed 
96-well plates at indicated conditions.
For coculture of purified Vγ2+ T cells with monocytes, Vγ2+ T cells were isolated as 
described above and monocytes were enriched by adherence to tissue culture flask as we 
previously described [44]. Purified Vγ2+ T cells were labeled with CFSE and then either left 
alone or mixed with monocytes in 96-well plates. In these two systems, cells were cultured 
for 7 days with media only, HMBPP, HMBPP plus IL-2, or HMBPP plus IL-23 and 
collected for proliferation assay.
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This was done as we previously described [24, 33, 44]. Cells were harvested at day 7 after 
culture and stained with Pacific blue-conjugated anti-CD3 (Clone SP34-2, BD, Franklin 
Lakes, NJ), PE conjugated anti-CD4 (clone OKT4, eBioscience, San Diego, CA), FITC-
conjugated Vγ2 (Clone 7A5, Pierce, Rockford, IL) and purified Vδ2 (clone 15D, Pierce) in 
combination of allophycocyanin-conjugated goat anti mouse IgG (Dako, Carpinteria, CA). 
After staining, cells were fixed with 2% formaldehyde-PBS (Protocol Formalin, Kalamazoo, 
MI) and subjected to run on a CyAn ADP flow cytometer (DakoCytomation, Carpinteria, 
CA). Lymphocytes were gated based on forward- and side-scatters, and pulse width and at 
least 40 000 gated events were analyzed by using Summit Data Acquisition and Analysis 
Software (Dako Cytomation). Further special gates and quadrants for data analysis were 
determined on nonstaining, specific antibody staining, and isotype control antibody 
background staining.
 Intracellular cytokine staining
This was done as we previously described [24, 33, 44]. Briefly, PBMCs were used in each 
reaction (round bottom 96-well plate) to measure T cells that could produce IFN-γ, TNF-α, 
IL-17, IL-22, and IL-23 in the absence or presence of HMBPP stimulation in vitro. 
Lymphocytes were incubated for 1 h with medium in presence of CD28 (1 μg/mL) and 
CD49d (1 μg/mL) mAbs in a 200 μL final volume in round bottom 96-well plates at 37°C, 
5% CO2, followed by 5 h incubation in the presence of brefeldin A (GolgiPlug, BD). After a 
total of 6-h incubation, cells in 96-well plate were transferred into 5 mL polystyrene round 
bottom tubes (BD) for surface and intracellular staining. Cells were washed once with 2% 
FBS-PBS and stained at RT for at least 15–30 min with surface marker Abs (CD3 and Vγ2/
Vδ2) and washed twice with 2% FBS-PBS. Cells were permeabilized for 45 min (cytofix/
cytoperm, BD) and washed twice by Perm buffer (BD), and then stained another 45 min for 
anti-IFN-γ Brilliant Violet 711 (clone 4S.B3, Biolegend) or anti-IL-23R-PE (clone 218213, 
R&D Systems), anti-IL-17A-allophycocyanin (clone eBio64DEC17, eBioscience), and anti-
IL-22 PE-Cy7 (clone 142928, R&D Systems), and repeated Perm wash twice. Last, cells 
were resuspended in 2% formaldehyde-PBS (Kalamazoo, MI) and subjected to flow 
cytometry analysis.
 ELISA
PBMCs from naïve, vaccinated or infected monkeys were cultured for 7 days with media, 
HMBPP, HMBPP+IL-2, or HMBPP+IL-23. The supernatants at day 5 or 7 were collected to 
measure the level of IFN-γ, IL-2, or IL-17 (kit from R&D system) by ELISA as we 
previously described [45].
 Cytokine neutralization, IL-23R blocking, and inhibition of PKC activation
For neutralization experiments, PBMCs from BCG-vaccinated monkeys were cultured with 
media, HMBPP, HMBPP+IL-23, HMBPP+IL-23+anti-IFN-γ (1 or 5 μg/mL), HMBPP
+IL-23+anti-IL-4 (5 μg/mL), HMBPP+IL-23+ anti-TGF-β (5 μg/mL) or HMBPP+IL-23+ 
anti-IL-17 (5 μg/mL), anti-IL-23R (5 μg/mL, R&D) or mouse IgG (5 μg/mL), with cytokine 
and Ab supplemented at day 0, 3, 5. At day 7, the cells were collected and stained. The 
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following neutralizing Abs were used: anti-IFN-γ (clone MD-1; eBioscience), and anti-TGF-
β (clone 9016; R&D systems), anti-IL-17 (Clone 133617, R&D Systems,), anti-IL-23R 
(clone 3D7, R&D Systems). Other primary and secondary mAbs or mouse isotype control 
IgG were listed previously [40].
For PKC inhibition experiment, PBMCs from BCG-vaccinated monkeys were cultured with 
media alone, HMBPP, HMBPP+IL-2, or HMBPP+IL-23; PKC inhibitors Gö6976 (500 nM, 
Calbiochem, San Diego, CA) and rottlerin (5 μM, Calbiochem) were added at days 3 and 5, 
respectively, as previously described [45]. At day 7, the cells were collected and stained.
 Statistical analysis
Statistical analysis was done by using GraphPad Prism software (GraphPad Software, Inc., 
La Jolla, CA). Data were analyzed by Student t test (parametric method) or by Mann-
Whitney test (non-parametric method). p < 0.05 was considered significant. Only p values < 
0.05 were shown in the text.
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Th17-related cytokines expand Vγ2Vδ2 T cells in an HMBPP-dependent fashion; IL-23 and 
other Th17-type cytokines induce greater expansion of HMBPP-stimulated Vγ2Vδ2 T cells 
from BCG-vaccinated monkeys than those from naïve animals. (A) Western blot (upper 
panel) was performed on culture supernatant samples to assess the presence of recombinant 
IL-17A, IL-17F, or IL-22 in the culture supernatant of L. lactis, using an anti-c-myc 
antibody. Loading control (ctr) is concentrated supernatant from induced L. lact1is without 
recombinant cytokine genes. Blot is representative of two independent experiments. SDS-
PAGE (lower panel) was performed to assess the extent to which these concentrated 
cytokines were purified by Ni-NTA system. Gel is representative of three independent 
experiments. (B) Representative flow cytometric histograms examining cellular expansion 
(upper panels) and proliferation (mid and lower panels) of Vγ2Vδ2T cells after 7-day 
coculture with HMBPP plus IL-17A, IL-17F, IL-22, IL-23, or IL-2. Cells were gated on 
CD3+ T cells from the BCG-vaccinated macaque (7245). Proliferation was determined based 
on the percentage dilution of CFSE fluorescence intensity. Flow plots are representative of 
three independent experiments. (C) Percentages of Vγ2Vδ2T cells in CD3+ T cells expanded 
after the 7-day culture with media, IL-17A, IL-17F, IL-22, IL-23, or IL-2 in the absence or 
presence of HMBPP were determined by flow cytometry. Data are shown as means +SEM 
from three BCG-vaccinated macaques and are pooled from two independent experiments. 
Recombinant human IL-22 from R&D system was also tested, with similar effects on 
Vγ2Vδ2 T cells (data not shown). ** p < 0.001, *p < 0.05 (Student t test). (D) PBMCs 
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culture with cytokine was used to assess the effect of BCG vaccination on the ability of 
Th17-related cytokines and IL-2 to expand HMBPP-stimulated Vγ2Vδ2 T cells. Data are 
shown as means + SEM of three naïve and three BCG-vaccinated monkeys and are pooled 
from two independent experiments after the 7-day culture with medium alone, HMBPP, 
HMBPP + IL-17A, HMBPP + IL-17F, HMBPP + IL-22, HMBPP + IL-23, or HMBPP + 
IL-2.
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Primary Mtb infection of macaques promotes the ability of IL-23 or IL-17/IL-22 to expand 
HMBPP-stimulated Vγ2Vδ2 T cells, and IL-23-driven expansion is reduced by blockade of 
IL-23 signaling. (A) Flow cytometry was performed to assess Th17-related cytokines for the 
ability to expand HMBPP-activated Vγ2Vδ2T cells in PBMCs. Data shown is representative 
of two Mtb-infected macaques. (B) Data were compiled from the in vitro stimulation 
experiments, as described above in Figure 1, using PBMCs before and after Mtb infection. 
Data are shown as mean + SEM (three macaques) and are from one experiment 
representative of two experiments performed. *p < 0.05 (Student t test). (C) PBMCs of 
macaques, which were vaccinated first with BCG, attenuated Mtb mutant (ΔlysA ΔsecA2) or 
saline, and 3 months later infected with Mtb, were obtained and assessed for recall 
expansion of Vγ2Vδ2 T cells by Th17-type cytokines and HMBPP in the in vitro stimulation 
experiments as described above. Postinfection PBMCs were obtained 6–7 weeks after Mtb 
infection. Anti-IL-23R Ab and control mouse IgG were used at a concentration of 5 (μg/mL. 
Data are shown as mean + SEM (n = four macaques) and are pooled from two independent 
experiments.
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HMBPP/IL-23-expanded Vγ2Vδ2 T cells from macaques infected with Mtb or vaccinated 
with BCG or rListeria ΔactA prfA*-ESAT6/Ag85B can produce IL-17, IL-22, IL-2, and 
IFN-γ. (A) Flow cytometry was used to assess the ability of HMBPP/IL-23-expanded 
Vγ2Vδ2 T cells (top panel) to produce IFN-γ, IL-22, and IL-17 or express IL-23R in 
PBMCs collected before (pre-Mtb) and week two after (post-Mtb) infection of macaques 
with Mtb. Cells were gated on CD3+ cells (see gating strategy in Supporting Information 
Fig. 1). Plots are from one macaque representative of three each analyzed in two 
independent experiments with similar results. (B) Numbers of Vγ2Vδ2 T effector cells 
producing IFN-γ, IL-22, IL-17, or expressing IL-23R, were assessed among total CD3+ T 
cells by in vitro stimulation with HMBPP/cytokines followed by intracellular cytokine 
staining as described in the Materials and Methods using PBMCs collected before and week 
2 after Mtb infection of three macaques. (C) Concentration of IFN-γ, IL-2, and IL-17 in the 
supernatants collected at day 5 from cultured PBMCs of four naïve and four rListeria ΔactA 
prfA*-vaccinated macaques was analyzed by ELISA. (D) Concentration of IFN-γ in the 
supernatants collected at day 5 from cultured PBMCs of BCG-vaccinated macaques was 
analyzed by ELISA. (B–D) Data are shown as mean + SEM of (B and D) three or (C) four 
macaques. Data are from one experiment representative of two experiments performed. *p < 
0.05; **p < 0.01; ***p < 0.001 (Student t test).
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